{
    "organizations": [],
    "uuid": "6ba7be4993a3b5b5a75cf899534587d8f05adb42",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-qiagen-nv-receives-fda-clearance-f/brief-qiagen-nv-receives-fda-clearance-for-ipsogen-jak2-rgq-pcr-kit-idUSFWN1PI189",
    "ord_in_thread": 0,
    "title": "BRIEF-Qiagen NV Receives FDA Clearance For Ipsogen Jak2 RGQ PCR Kit",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - Qiagen Nv:\n* QIAGEN NV SAYS RECEIVED CLEARANCE FOR ITS IPSOGEN JAK2 RGQ PCR KIT FROM U.S. FDA FOR ADDITIONAL USE IN DIAGNOSIS OF ALL MYELOPROLIFERATIVE NEOPLASMS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-24T05:17:00.000+02:00",
    "crawled": "2018-01-24T15:35:45.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "qiagen",
        "nv",
        "qiagen",
        "nv",
        "say",
        "received",
        "clearance",
        "ipsogen",
        "jak2",
        "rgq",
        "pcr",
        "kit",
        "fda",
        "additional",
        "use",
        "diagnosis",
        "myeloproliferative",
        "neoplasm",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}